Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
268.89%
Change (1 year)
Categories
EPS for Corbus Pharmaceuticals (CRBP)
EPS in 2023 (TTM): -$11.00
According to Corbus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$11.00. In 2022 the company made an earnings per share (EPS) of -$10.15 an increase over its 2021 EPS that were of -$11.70.
EPS history for Corbus Pharmaceuticals from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$11.00 | 8.37% |
| 2022 | -$10.15 | -13.25% |
| 2021 | -$11.70 | -73.65% |
| 2020 | -$44.40 | 30.97% |
| 2019 | -$33.90 | 15.31% |
| 2018 | -$29.40 | 48.48% |
| 2017 | -$19.80 | 34.69% |
| 2016 | -$14.70 | 75% |
| 2015 | -$8.40 | 185.12% |
| 2014 | -$2.95 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | -$0.93 | -91.55% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.27 | -102.45% | 🇺🇸 USA |
 Advaxis ADXS | -$5.97 | -45.73% | 🇺🇸 USA |